Drug factory · FDA FEI 3012112664
Mas Management Group, Inc.
Los Angeles, California, United States
Matched to FDA's records by company name, because this plant's registration on the label has expired.
No problems found at FDA's last inspection, Sep 24, 2018.
No Action Indicated: inspectors found no objectionable conditions.
1 drug inspection on record since 2018: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Acyclovir | Repackages it | MAS Management Group Inc. | 69677-104, 69677-105 |
| Azithromycin | Relabels it | MAS Management Group Inc. | 69677-129 |
| Benzalkonium and Furosemide | Makes it | MAS Management Group Inc. | 69677-030 |
| Celecoxib | Repackages it | MAS Management Group Inc. | 69677-154 |
| Furosemide | Repackages it | MAS Management Group Inc. | 69677-204 |
| Ibuprofen | Repackages it | MAS Management Group Inc. | 69677-225, 69677-226 |
| Meclizine | Repackages it | MAS Management Group Inc. | 69677-153 |
| Naproxen | Repackages it | MAS Management Group Inc. | 69677-171 |
| Phentermine | Repackages it | MAS Management Group Inc. | 69677-293 |
| Tramadol | Repackages it | MAS Management Group Inc. | 69677-316 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 24, 2018 | No problems found | Drug Quality Assurance | — |